Identification of potential cruzain inhibitors using de novo design, molecular docking and dynamics simulations studies

被引:5
作者
Bhowmick, Shovonlal [1 ]
Chorge, Rekha Dhondiram [2 ]
Jangam, Chaitanya Sadashiv [2 ]
Bharatrao, Lomate Dhanraj [2 ]
Patil, Pritee Chunarkar [2 ]
Chikhale, Rupesh V. [3 ]
Islam, Md. Ataul [4 ,5 ,6 ,7 ]
机构
[1] Univ Calcutta, Dept Chem Technol, Kolkata, India
[2] Bharati Vidyapeeth Deemed Univ, Rajiv Gandhi Inst IT & Biotechnol, Dept Bioinformat, Pune, Maharashtra, India
[3] Univ East Anglia, Sch Pharm, Norwich, Norfolk, England
[4] Univ Manchester, Fac Biol Med & Hlth, Sch Hlth Sci, Div Pharm & Optometry, Oxford Rd, Manchester M13 9PL, Lancs, England
[5] Univ Kwazulu Natal, Sch Hlth Sci, Durban, South Africa
[6] Univ Pretoria, Fac Hlth Sci, Dept Chem Pathol, Pretoria, South Africa
[7] Tshwane Acad Div, Natl Hlth Lab Serv, Pretoria, South Africa
关键词
CHAGAS-DISEASE;
D O I
10.1080/07391102.2019.1664334
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:4005 / 4015
页数:11
相关论文
共 15 条
[1]   Access to benznidazole for Chagas disease in the United States-Cautious optimism? [J].
Alpern, Jonathan D. ;
Lopez-Velez, Rogelio ;
Stauffer, William M. .
PLOS NEGLECTED TROPICAL DISEASES, 2017, 11 (09)
[2]   Dissecting a novel allosteric mechanism of cruzain: A computer-aided approach [J].
Alvarez, Lilian Hernandez ;
Barreto Gomes, Diego Enry ;
Hernandez Gonzalez, Jorge Enrique ;
Pascutti, Pedro Geraldo .
PLOS ONE, 2019, 14 (01)
[3]   Nonpeptidic Tetrafluorophenoxymethyl Ketone Cruzain Inhibitors as Promising New Leads for Chagas Disease Chemotherapy [J].
Brak, Katrien ;
Kerr, Iain D. ;
Barrett, Kimberly T. ;
Fuchi, Nobuhiro ;
Debnath, Moumita ;
Ang, Kenny ;
Engel, Juan C. ;
McKerrow, James H. ;
Doyle, Patricia S. ;
Brinen, Linda S. ;
Ellman, Jonathan A. .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (04) :1763-1773
[4]   Molecular Docking Studies Applied to a Dataset of Cruzain Inhibitors [J].
da Silva-Junior, Edeildo Ferreira ;
Barcellos Franca, Paulo Henrique ;
Ribeiro, Frederico Favaro ;
Bezerra Mendonca-Junior, Francisco Jaime ;
Scotti, Luciana ;
Scotti, Marcus Tullius ;
de Aquino, Thiago Men-Donca ;
de Araujo-Junior, Joao Xavier .
CURRENT COMPUTER-AIDED DRUG DESIGN, 2018, 14 (01) :68-78
[5]   SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules [J].
Daina, Antoine ;
Michielin, Olivier ;
Zoete, Vincent .
SCIENTIFIC REPORTS, 2017, 7
[6]   A therapeutic preconceptional vaccine against Chagas disease: A novel indication that could reduce congenital transmission and accelerate vaccine development [J].
Dumonteil, Eric ;
Herrera, Claudia ;
Buekens, Pierre .
PLOS NEGLECTED TROPICAL DISEASES, 2019, 13 (01)
[7]   Safety Profile of Nifurtimox for Treatment of Chagas Disease in the United States [J].
Forsyth, Colin J. ;
Hernandez, Salvador ;
Olmedo, Wilman ;
Abuhamidah, Adieb ;
Traina, Mahmoud I. ;
Sanchez, Daniel R. ;
Soverow, Jonathan ;
Meymandi, Sheba K. .
CLINICAL INFECTIOUS DISEASES, 2016, 63 (08) :1056-1062
[8]   Structure-Based Virtual Screening and In Vitro Evaluation of New Trypanosoma cruzi Cruzain Inhibitors [J].
Herrera-Mayorga, Veronica ;
Lara-Ramirez, Edgar E. ;
Chacon-Vargas, Karla F. ;
Aguirre-Alvarado, Charmina ;
Rodriguez-Paez, Lorena ;
Alcantara-Farfan, Veronica ;
Cordero-Martinez, Joaquin ;
Nogueda-Torres, Benjamin ;
Reyes-Espinosa, Francisco ;
Bocanegra-Garcia, Virgilio ;
Rivera, Gildardo .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (07)
[9]   Reversible Cysteine Protease Inhibitors Show Promise for a Chagas Disease Cure [J].
Ndao, Momar ;
Beaulieu, Christian ;
Black, W. Cameron ;
Isabel, Elise ;
Vasquez-Camargo, Fabio ;
Nath-Chowdhury, Milli ;
Masse, Frederic ;
Mellon, Christophe ;
Methot, Nathalie ;
Nicoll-Griffith, Deborah A. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (02) :1167-1178
[10]   Novel Cruzain Inhibitors for the Treatment of Chagas' Disease [J].
Rogers, Kathleen E. ;
Keranen, Henrik ;
Durrant, Jacob D. ;
Ratnam, Joseline ;
Doak, Allison ;
Arkin, Michelle R. ;
McCammon, J. Andrew .
CHEMICAL BIOLOGY & DRUG DESIGN, 2012, 80 (03) :398-405